| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WVE | Ordinary Shares | Purchase | $20.4M | +9.48M | +122.77% | $2.15 | 17.2M | Jun 16, 2022 | See Footnotes | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WVE | Pre-Funded Warrants (Right to Buy) | Purchase | $15.3M | +7.09M | $2.15 | 7.09M | Jun 16, 2022 | Ordinary Shares | 7.09M | $0.00 | See Footnotes | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | These Securities are held directly by RA Capital Healthcare Fund, L.P. (the "Fund") |
| F2 | RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. |
| F3 | The Pre-Funded Warrants are exercisable immediately and will be exercisable until exercised in full. The Pre-Funded Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's ordinary shares would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's ordinary shares outstanding immediately after giving effect to such exercise. |
Dr. Kolchinsky serves on the Issuer's board of directors.